UNLABELLED: Chemokines are known to participate in allograft rejection by mediating leukocyte trafficking. Despite redundancy in chemokine family, several chemokine-chemokine receptor interactions have proven critical in alloimmune responses. We sought to determine the effect of combined blockade of CXCR3 and CCR5, two critical chemokine receptors, in acute rejection. METHODS: Heterotopic heart transplantation was performed using BALB/c to B6/129 mice deficient in CCR5. Following transplantation these mice were treated with goat anti-CXCR3 serum every other day. In the control group, BALB/c hearts were transplanted in wild type B6/129 recipients and treated with goat serum alone. No immunosuppression was given to either group. Recipient mice were then assessed daily for allograft function by abdominal palpation, and graft survival was confirmed by laparotomy. RESULTS: The donor hearts in the control group were rejected at 6 +/- 1 days posttransplantation. Combined blockade of CXCR3 and CCR5 prolonged allograft survival versus control; all allografts survived to 24 days. In addition, there was a decrease in graft infiltrating CD4 and CD8 lymphocytes in the experimental group at 24 days. CONCLUSION: Combined CXCR3 and CCR5 blockade is effective in prolonging allograft survival in a fully MHC mismatched murine model. Combined chemokine blockade holds promise in control of acute rejection in organ transplantation.
UNLABELLED: Chemokines are known to participate in allograft rejection by mediating leukocyte trafficking. Despite redundancy in chemokine family, several chemokine-chemokine receptor interactions have proven critical in alloimmune responses. We sought to determine the effect of combined blockade of CXCR3 and CCR5, two critical chemokine receptors, in acute rejection. METHODS: Heterotopic heart transplantation was performed using BALB/c to B6/129 mice deficient in CCR5. Following transplantation these mice were treated with goat anti-CXCR3 serum every other day. In the control group, BALB/c hearts were transplanted in wild type B6/129 recipients and treated with goat serum alone. No immunosuppression was given to either group. Recipient mice were then assessed daily for allograft function by abdominal palpation, and graft survival was confirmed by laparotomy. RESULTS: The donor hearts in the control group were rejected at 6 +/- 1 days posttransplantation. Combined blockade of CXCR3 and CCR5 prolonged allograft survival versus control; all allografts survived to 24 days. In addition, there was a decrease in graft infiltrating CD4 and CD8 lymphocytes in the experimental group at 24 days. CONCLUSION: Combined CXCR3 and CCR5 blockade is effective in prolonging allograft survival in a fully MHC mismatched murine model. Combined chemokine blockade holds promise in control of acute rejection in organ transplantation.
Authors: A Hoerning; S Köhler; C Jun; B Tebbe; J Fu; J Menke; B Wilde; S Dolff; T Feldkamp; D M Briscoe; A Kribben; P F Hoyer; O Witzke Journal: Scand J Immunol Date: 2012-09 Impact factor: 3.487
Authors: Jason M Zimmerer; Bryce A Ringwald; Steven M Elzein; Christina L Avila; Robert T Warren; Mahmoud Abdel-Rasoul; Ginny L Bumgardner Journal: Transplantation Date: 2019-09 Impact factor: 4.939
Authors: Jaafar El Annan; Sunil K Chauhan; Tatiana Ecoiffier; Qiang Zhang; Daniel R Saban; Reza Dana Journal: Invest Ophthalmol Vis Sci Date: 2009-04-01 Impact factor: 4.799
Authors: Marija Mladic; Danny J Scholten; Maikel Wijtmans; David Falck; Rob Leurs; Wilfried M A Niessen; Martine J Smit; Jeroen Kool Journal: Anal Bioanal Chem Date: 2015-07-12 Impact factor: 4.142
Authors: Elisabet Van Loon; Baptiste Lamarthée; Thomas Barba; Sandra Claes; Maarten Coemans; Henriette de Loor; Marie-Paule Emonds; Priyanka Koshy; Dirk Kuypers; Paul Proost; Aleksandar Senev; Ben Sprangers; Claire Tinel; Olivier Thaunat; Amaryllis H Van Craenenbroeck; Dominique Schols; Maarten Naesens Journal: Front Immunol Date: 2022-02-23 Impact factor: 7.561